A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
Titel:
A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
Auteur:
Mascarenhas, J. Marcellino, B.K. Lu, M. Kremyanskaya, M. Fabris, F. Sandy, L. Mehrotra, M. Houldsworth, J. Najfeld, V. El Jamal, S. Petersen, B. Moshier, E. Hoffman, R.